טוען...
Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma
INTRODUCTION: A combination of pemetrexed and cisplatin has been shown to improve the outcome in patients with malignant pleural mesothelioma (MPM), however, there is a great heterogeneity in treatment response among patients. The aim of our study was to evaluate the influence of polymorphisms in fo...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Versita, Warsaw
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078035/ https://ncbi.nlm.nih.gov/pubmed/24991206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2013-0086 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|